What is a stock summary page? Click here for an overview.
Business Description
Elevance Health Inc
NAICS : 524114
SIC : 6324
ISIN : US0367521038
Compare
Compare
Traded in other countries / regions
ELV.USA0HG8.UKE1LV34.BrazilELV.MexicoA58.GermanyELV.Austria1ANTM.Italy IPO Date
2009-12-23Description
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of December 2024. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.27 | |||||
| Equity-to-Asset | 0.35 | |||||
| Debt-to-Equity | 0.76 | |||||
| Debt-to-EBITDA | 2.98 | |||||
| Interest Coverage | 7.67 | |||||
| Piotroski F-Score | 3/9 | |||||
| Beneish M-Score | -3.18 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10.6 | |||||
| 3-Year EBITDA Growth Rate | 3.2 | |||||
| 3-Year EPS without NRI Growth Rate | 9.7 | |||||
| 3-Year FCF Growth Rate | -12.8 | |||||
| 3-Year Book Growth Rate | 6.8 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 11.56 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 8.36 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 99.98 | |||||
| 9-Day RSI | 99.27 | |||||
| 14-Day RSI | 96.74 | |||||
| 3-1 Month Momentum % | 5.95 | |||||
| 6-1 Month Momentum % | -15.37 | |||||
| 12-1 Month Momentum % | -4.87 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.43 | |||||
| Dividend Payout Ratio | 0.21 | |||||
| 3-Year Dividend Growth Rate | 13 | |||||
| Forward Dividend Yield % | 1.53 | |||||
| 5-Year Yield-on-Cost % | 2.93 | |||||
| 3-Year Average Share Buyback Ratio | 2 | |||||
| Shareholder Yield % | 1.45 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Net Margin % | 3.38 | |||||
| FCF Margin % | 2.55 | |||||
| ROE % | 14.43 | |||||
| ROA % | 5.27 | |||||
| ROIC % | 7.94 | |||||
| 3-Year ROIIC % | 0.75 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 16.75 | |||||
| Forward PE Ratio | 12.81 | |||||
| PE Ratio without NRI | 13.44 | |||||
| Shiller PE Ratio | 20.19 | |||||
| Price-to-Owner-Earnings | 23.42 | |||||
| PEG Ratio | 1.53 | |||||
| PS Ratio | 0.56 | |||||
| PB Ratio | 2.36 | |||||
| Price-to-Tangible-Book | 103.35 | |||||
| Price-to-Free-Cash-Flow | 21.98 | |||||
| Price-to-Operating-Cash-Flow | 17.22 | |||||
| EV-to-EBIT | 13.22 | |||||
| EV-to-Forward-EBIT | 11.03 | |||||
| EV-to-EBITDA | 11.46 | |||||
| EV-to-Forward-EBITDA | 10.27 | |||||
| EV-to-Revenue | 0.68 | |||||
| EV-to-Forward-Revenue | 0.62 | |||||
| EV-to-FCF | 26.4 | |||||
| Price-to-GF-Value | 0.74 | |||||
| Price-to-Projected-FCF | 0.77 | |||||
| Price-to-DCF (Earnings Based) | 0.61 | |||||
| Price-to-DCF (FCF Based) | 1.18 | |||||
| Price-to-Median-PS-Value | 0.82 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.44 | |||||
| Price-to-Graham-Number | 7.86 | |||||
| Earnings Yield (Greenblatt) % | 7.56 | |||||
| FCF Yield % | 4.69 | |||||
| Forward Rate of Return (Yacktman) % | 15.95 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Elevance Health Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil MXN) | 3,313,510.587 | ||
| EPS (TTM) (MXN) | 462.148 | ||
| Beta | -0.16 | ||
| 3-Year Sharpe Ratio | -0.49 | ||
| 3-Year Sortino Ratio | -0.63 | ||
| Volatility % | 27.54 | ||
| 14-Day RSI | 96.74 | ||
| 14-Day ATR (MXN) | 51.880153 | ||
| 20-Day SMA (MXN) | 8290.678 | ||
| 12-1 Month Momentum % | -4.87 | ||
| 52-Week Range (MXN) | 7580 - 11202 | ||
| Shares Outstanding (Mil) | 226.39 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Elevance Health Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Elevance Health Inc Stock Events
| Event | Date | Price (MXN) | ||
|---|---|---|---|---|
| No Event Data | ||||
Elevance Health Inc Frequently Asked Questions
What is Elevance Health Inc(MEX:ELV)'s stock price today?
The current price of MEX:ELV is MXN8950.00. The 52 week high of MEX:ELV is MXN11202.00 and 52 week low is MXN7580.00.
When is next earnings date of Elevance Health Inc(MEX:ELV)?
The next earnings date of Elevance Health Inc(MEX:ELV) is 2025-04-22.
Does Elevance Health Inc(MEX:ELV) pay dividends? If so, how much?
The Dividend Yield %  of Elevance Health Inc(MEX:ELV) is 1.43% (As of Today), Highest Dividend Payout Ratio of Elevance Health Inc(MEX:ELV) was 0.28. The lowest was 0.17. And the median was 0.2. The  Forward Dividend Yield % of Elevance Health Inc(MEX:ELV) is 1.53%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers